BRK is a recently described non receptor protein tyrosine kinase whose
mRNA was found to be expressed in human breast tumours and breast can
cer cell lines, Expression of BRK in fibroblasts and mammary epithelia
l cells has been shown to enhance their ability to grow anchorage inde
pendently, and mammary epithelial cells expressing BRK acquire a poten
tiated mitogenic response to epidermal growth factor, In order to inve
stigate further the expression of BRK in breast cancers, we have isola
ted monoclonal antibodies specifically recognising the protein, Wherea
s BRK expression was low or undetectable in normal mammary tissue and
benign lesions, approximately two-thirds of breast tumours expressed a
ppreciable levels, and 27% of tumours over expressed BRK by fivefold o
r more (up to 43x), This expression pattern was mirrored in a comparis
on of cell lines derived either from normal mammary epithelial cells o
r from carcinomas, BRK expression was found to be constant throughout
the cell cycle, and did not vary with cell proliferation rate, A consi
deration of this expression data, in conjunction with BRK's demonstrat
ed ability to deregulate the proliferation of mammary epithelial cells
, supports the hypothesis that the over expression of BRK in a high pr
oportion of breast carcinomas is a functionally important factor in th
eir evolution.